| 1. |
Ayuso C, Millan JM.Retinitis pigmentosa and allied conditions today: a paradigm of translational research[J]. Genome Med, 2010, 2(5): 34. DOI: 10.1186/gm155.
|
| 2. |
Smith RJ, Berlin CI, Hejtmancik JF, et al. Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium[J]. Am J Med Genet, 1994, 50(1): 32-38.
|
| 3. |
冯竞仰, 樊莹.黄斑囊样水肿的病因及治疗进展[J]. 眼科新进展, 2010, 30(12): 1196-1200.Feng JY, Fan Y.Recent advances in treatment and etiology of cystoid macular edema[J]. Rec Adv Ophthalmo, 2010, 30(12): 1196-1200.
|
| 4. |
Gelisken O, Ozcetin H.Treatment of chronic macular edema with low dosage zcetazamide[J], Bull Soc Belge Ophtalmol, 1990, 238: 153-160.
|
| 5. |
Hufendiek K, Hufendiek K, Panagakis G, et al. Visual and morphological outcomes of bevacizumab (Avastin) versus ranibizumab (Lucentis) treatment for retinal angiomatous proliferation[J]. Int Ophthalmol, 2012, 32(3): 259-268. DOI: 10.1007/s10792-012-9562-0.
|
| 6. |
连海燕, 宋艳萍, 丁琴, 等.康柏西普与雷珠单抗玻璃体腔注射治疗视网膜中央静脉阻塞黄斑水肿短期疗效对比观察[J]. 中华眼底病杂志, 2016, 32(4), 367-371. DOI: 10.3760/cma.j.issn.1005-1015.2016.04.006.Lian HY, Song YP, Ding Q, et alShort-tern efficacy of conbercept versus ranibizumab for macular edema in central retinal vein occlusion[J]. Chin J Ocul Fundus Dis, 2016, 32(4), 367-371. DOI: 10.3760/cma.j.issn.1005-1015.2016.04.006.
|
